IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.929
EU - Europa 2.937
AS - Asia 1.637
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
AF - Africa 3
Totale 9.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.916
IE - Irlanda 1.393
SG - Singapore 644
CN - Cina 622
SE - Svezia 334
IT - Italia 330
TR - Turchia 286
DE - Germania 262
UA - Ucraina 220
GB - Regno Unito 129
FI - Finlandia 75
FR - Francia 72
BE - Belgio 35
IN - India 34
VN - Vietnam 30
BR - Brasile 25
CZ - Repubblica Ceca 22
RU - Federazione Russa 19
CA - Canada 9
EU - Europa 9
NL - Olanda 8
CH - Svizzera 7
GR - Grecia 7
HK - Hong Kong 6
RO - Romania 6
AU - Australia 5
ES - Italia 3
IL - Israele 3
LU - Lussemburgo 3
MK - Macedonia 3
AT - Austria 2
CO - Colombia 2
DK - Danimarca 2
ID - Indonesia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
HR - Croazia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 9.554
Salva come PNG Salva come JPEG
Città #
Dublin 1.390
Chandler 1.137
Jacksonville 942
Singapore 475
Boardman 386
New York 224
Izmir 208
Ashburn 162
Lawrence 161
Princeton 161
Ann Arbor 151
Nanjing 125
Wilmington 123
Beijing 102
L'aquila 99
San Mateo 83
Dearborn 63
Los Angeles 63
Woodbridge 55
L’Aquila 50
Nanchang 49
Milan 45
Shanghai 34
Seattle 32
Brussels 31
Dallas 30
Dong Ket 30
Mountain View 30
Kunming 29
Shenyang 29
Des Moines 28
Hebei 24
Pescara 23
Tianjin 21
Brno 20
Jinan 20
Kitzingen 19
Verona 19
Helsinki 18
Jiaxing 18
Cedar Knolls 17
Munich 17
Zhengzhou 17
Pune 16
Changsha 15
Houston 15
Ningbo 12
Norwalk 12
Bremen 11
Hangzhou 11
Hefei 11
Washington 11
Lappeenranta 10
Philadelphia 9
Frankfurt am Main 8
Grafing 8
Guangzhou 8
Edinburgh 7
Santa Clara 7
Changchun 6
Redwood City 6
Stockholm 6
Chengdu 5
Fremont 5
Lanzhou 5
Moscow 5
Phoenix 5
Rome 5
Zurich 5
Berlin 4
Hong Kong 4
Jinhua 4
Leuven 4
Mumbai 4
New Delhi 4
Ponte A Égola 4
St Petersburg 4
Taizhou 4
Aquila 3
Auburn Hills 3
Forest City 3
Fuzhou 3
London 3
Naples 3
Paris 3
Redmond 3
Amsterdam 2
Athens 2
Atlanta 2
Auckland 2
Baoding 2
Brisbane 2
Bucharest 2
Cassano d'Adda 2
Charlotte 2
Chicago 2
Civitella Messer Raimondo 2
Delhi 2
Fairfield 2
Harbin 2
Totale 7.072
Salva come PNG Salva come JPEG
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 116
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 103
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 101
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 98
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 97
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 96
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 95
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 95
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 94
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 94
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 92
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 92
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 92
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 91
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 86
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 84
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 82
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 82
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 81
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 81
Stem cell therapies for systemic sclerosis 79
A comprehensive review on adult onset Still's disease 79
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 78
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 77
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 77
Cardiovascular disease in primary sjögren’s syndrome 77
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 76
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 75
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 75
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 75
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 75
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 74
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 74
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 73
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 72
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 71
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 71
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 71
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 70
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 70
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 68
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 68
Interstitial lung disease in systemic sclerosis: current and future treatment. 68
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 66
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 65
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 64
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 64
Methotrexate: an old new drug in autoimmune disease. 63
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 63
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 63
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 62
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 62
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 61
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 61
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 60
Computed Tomography and MR Imaging in Rheumatoid Arthritis 60
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 59
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 59
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 58
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 58
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 58
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 58
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 57
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 57
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 57
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 57
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 56
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 55
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 55
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 55
Angiogenic cytokines and growth factors in systemic sclerosis. 54
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 54
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 54
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 54
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 54
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 54
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 53
IL LABORATORIO IN REUMATOLOGIA 53
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 53
POTENTIAL OF STEM CELLS IN THE TREATMENT OF RHEUMATIC DIDEASE 52
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 52
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 52
Il laboratorio nelle malattie reumatiche 51
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 51
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 51
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 51
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review 51
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 50
The Vessels Contribute to Fibrosis in Systemic Sclerosis 50
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 50
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 50
IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients 49
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 49
Diagnostic and interventional radiology fundamentals of synovial pathology 49
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 48
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 48
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 47
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 47
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 47
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 47
Totale 6.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020775 0 0 0 0 24 172 169 33 129 61 22 165
2020/20211.193 31 132 23 155 155 48 157 21 153 44 206 68
2021/2022803 39 24 153 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/20251.118 118 79 404 213 304 0 0 0 0 0 0 0
Totale 9.884